T1	Participants 66 161	children, adolescents, and adults with mental retardation and pervasive developmental disorders
T2	Participants 241 346	children, adolescents, and adults with mental retardation (MR) and pervasive developmental disorders (PDD
T3	Participants 600 703	children, adolescents, and adults with MR and PDDs, serum prolactin was measured in a 21-subject subset
T4	Participants 881 936	children and adolescents (n=10), mean age of 12.5 years
T5	Participants 1070 1100	adults, mean age of 35.3 years
